Comparative Benchmarking
In the context of the broader market, PBM competes directly with industry leaders such as BDRX and HELP. With a market capitalization of $4.36M, it holds a significant position in the sector. When comparing efficiency, PBM's gross margin of N/A stands against BDRX's N/A and HELP's N/A. Such benchmarking helps identify whether Psyence Biomedical Ltd is trading at a premium or discount relative to its financial performance.
